marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Marinus Pharmaceuticals Financial Ratios 2011-2024 | MRNS
Annual Financial Ratios Marinus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.5 | -14.4 | -4.4 | -5.0 | -2.1 | -3.5 | -9.4 | -0.8 | -3.5 | -6.3 | -23.6 | -46.4 | - |
P/S |
16.0 | 11.2 | 28.4 | 197.3 | - | - | - | - | - | - | - | 654.1 | - |
EPS |
-2.6 | -0.5 | -2.7 | -2.8 | -1.0 | -0.9 | -0.8 | -1.5 | -1.7 | -2.2 | -19.6 | - | - |
EV (Enterprise Value) |
530 M | 189 M | 396 M | 214 M | 34.6 M | 69.2 M | 146 M | 6.99 M | 47.1 M | 27.6 M | 117 M | 69.9 M | - |
EBITDA per Share |
-2.44 | -2.88 | -2.63 | -2.48 | -3.97 | -3.62 | -3.21 | -5.79 | -6.55 | -7.75 | -2.79 | -0.699 | - |
EV/EBITDA |
-3.8 | -3.0 | -0.4 | -1.7 | -7.6 | -0.1 | -1.7 | -2.1 | -22.1 | -40.3 | - | ||
PEG |
0.63 | -196.4 | 0.41 | -0.17 | 0.21 | 0.28 | -0.21 | -0.07 | -0.15 | 0.03 | 0.4 | 1.73 | - |
P/B |
29.6 | 2.5 | 8.2 | 2.5 | 1.3 | 1.9 | 3.0 | 1.1 | 1.8 | 1.7 | 13.1 | 15.6 | - |
P/CF |
-4.2 | -2.5 | -7.9 | -5.6 | -2.3 | -4.7 | -9.2 | -0.9 | -4.2 | -7.9 | -18.7 | -53.0 | - |
ROE % |
-843.45 | -17.08 | -184.68 | -49.18 | -61.66 | -53.75 | -32.58 | -133.35 | -52.96 | -26.32 | -55.72 | -33.68 | - |
ROA % |
-82.74 | -7.64 | -72.18 | -44.85 | -54.76 | -48.82 | -31.15 | -91.08 | -41.65 | -21.57 | -44.57 | -16.22 | - |
ROCE % |
-784.28 | -97.23 | -181.23 | -48.62 | -59.93 | -54.41 | -32.76 | -120.88 | -46.78 | -24.74 | -56.58 | -34.11 | - |
Current Ratio |
1.1 | 1.8 | 1.6 | 13.6 | 11.7 | 10.7 | 21.4 | 3.7 | 7.8 | 24.6 | 5.0 | 1.9 | - |
DSO |
59.8 | 64.3 | 31.3 | 349.7 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
59.8 | 64.3 | 31.3 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
59.8 | 64.3 | 31.3 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Marinus Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.42 | -0.63 | -0.68 | - | -0.61 | -0.61 | -0.67 | - | 1.93 | -1.06 | -0.52 | - | -0.53 | -0.65 | -0.74 | - | -0.51 | -0.63 | -1.27 | -0.25 | -1.05 | -0.24 | -0.24 | -0.24 | -0.27 | -0.24 | -0.15 | -0.12 | -0.15 | -0.21 | -0.26 | -0.31 | -0.33 | -0.46 | -0.37 | -0.45 | -0.35 | -0.37 | -0.5 | -0.26 | -0.22 | -7.98 | -7.09 | -5.54 | -4.58 | -5.66 | -3.82 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.63 | - | - | - | -0.63 | - | -0.8 | -0.98 | -0.45 | - | -0.51 | -0.64 | -0.74 | - | -0.51 | -0.63 | -0.87 | - | -1.04 | -0.24 | -0.24 | - | -0.28 | -0.24 | -0.15 | - | -0.15 | -0.2 | -0.26 | - | -0.33 | -0.45 | -0.36 | - | -0.39 | -0.36 | -0.49 | - | -0.26 | -5.88 | -5.71 | - | -2.67 | -3.53 | - | - | - | - | - | - | - | - | - |
ROE % |
286.81 | 190.06 | 58.69 | -156.97 | -67.60 | 82.24 | -683.08 | -779.55 | -804.40 | -918.63 | -122.68 | -73.45 | -84.86 | -71.42 | -57.78 | -36.45 | -62.32 | -74.08 | -83.51 | -90.85 | -79.79 | -72.87 | -65.93 | -53.75 | -47.12 | -38.05 | -31.98 | -32.58 | -52.41 | -75.32 | -109.13 | -133.35 | -121.57 | -102.05 | -71.62 | -52.96 | -45.51 | -38.99 | -35.83 | -26.32 | -15.25 | -9.17 | 1.69 | 7.12 | 4.81 | 2.79 | - | - | - | - | - | - | - | - | - |
ROA % |
-123.79 | -102.14 | -76.87 | -47.60 | -7.95 | 48.12 | 27.94 | -10.15 | -22.43 | -74.36 | -57.37 | -51.61 | -62.02 | -60.15 | -51.51 | -33.23 | -48.82 | -52.38 | -54.54 | -54.76 | -52.61 | -53.41 | -53.47 | -48.82 | -43.18 | -35.29 | -30.16 | -31.15 | -42.46 | -56.15 | -77.10 | -91.08 | -84.71 | -72.48 | -52.86 | -41.66 | -36.09 | -31.09 | -28.87 | -21.57 | -26.18 | -33.21 | -40.82 | -36.37 | -24.58 | -14.23 | - | - | - | - | - | - | - | - | - |
ROCE % |
259.61 | 170.00 | 47.09 | -151.60 | -188.30 | -166.98 | -877.63 | -843.54 | -867.96 | -855.68 | -114.91 | -72.68 | -84.12 | -71.14 | -58.01 | -36.76 | -60.09 | -71.98 | -81.41 | -65.39 | -81.81 | -74.90 | -67.90 | -39.38 | -46.64 | -37.48 | -31.25 | -24.32 | -53.97 | -76.36 | -109.76 | -103.87 | -114.21 | -94.89 | -64.74 | -36.09 | -42.01 | -37.60 | -34.51 | -20.33 | -18.14 | -10.03 | 0.62 | 4.91 | 4.91 | 2.72 | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.5 | 0.7 | 0.9 | 1.1 | 1.4 | 1.4 | 1.6 | 1.8 | 1.8 | 1.1 | 1.4 | 1.6 | 2.0 | 4.2 | 7.2 | 11.3 | 11.3 | 11.3 | 11.3 | 8.9 | 8.9 | 8.9 | 8.9 | 10.9 | 10.9 | 10.9 | 10.9 | 22.8 | 22.8 | 22.8 | 22.8 | 3.1 | 3.1 | 3.1 | 3.1 | 4.7 | 4.7 | 4.7 | 4.7 | 5.5 | 5.5 | 5.5 | 5.5 | 5.0 | 5.0 | 5.0 | - | - | - | - | - | - | - | - | - |
DSO |
38.9 | 39.4 | 43.4 | - | 59.2 | 127.0 | 79.3 | - | 124.8 | 139.9 | 16.5 | - | 11.2 | - | 41.6 | - | 439.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | 311.1 | 304.3 | - | 123.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
38.9 | 39.4 | 43.4 | - | 59.2 | 127.0 | 79.3 | - | 124.8 | 139.9 | 16.5 | - | 11.2 | - | 41.6 | - | 439.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
38.9 | 39.4 | 43.4 | - | 59.2 | 127.0 | 79.3 | - | 124.8 | -171.2 | -287.9 | - | -112.4 | - | 41.6 | - | 439.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency